Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer (2011)
- Authors:
- USP affiliated authors: COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP
- Schools: FMRP; FCFRP
- DOI: 10.1007/s00280-011-1554-7
- Subjects: NEOPLASIAS MAMÁRIAS; FARMACOTERAPIA; FARMACOCINÉTICA
- Language: Inglês
- Imprenta:
- Place of publication: Heildelberg
- Date published: 2011
- Source:
- Título do periódico: Cancer Chemotherapy and Pharmacology
- ISSN: 0344-5704
- Volume/Número/Paginação/Ano: v. 68, n. 4, p. 897-904, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FERNANDES, Bruno José Dumêt et al. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, v. 68, n. 4, p. 897-904, 2011Tradução . . Disponível em: http://dx.doi.org/10.1007/s00280-011-1554-7. Acesso em: 29 jun. 2022. -
APA
Fernandes, B. J. D., Silva, C. de M., Andrade, J. M. de, Matthes, Â. do C. S., Coelho, E. B., & Lanchote, V. L. (2011). Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer. Cancer Chemotherapy and Pharmacology, 68( 4), 897-904. doi:10.1007/s00280-011-1554-7 -
NLM
Fernandes BJD, Silva C de M, Andrade JM de, Matthes  do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2022 jun. 29 ] Available from: http://dx.doi.org/10.1007/s00280-011-1554-7 -
Vancouver
Fernandes BJD, Silva C de M, Andrade JM de, Matthes  do CS, Coelho EB, Lanchote VL. Pharmacokinetics of cyclophosphamide enantiomers in patients with breat cancer [Internet]. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 4): 897-904.[citado 2022 jun. 29 ] Available from: http://dx.doi.org/10.1007/s00280-011-1554-7 - Pharmacokinetics of cyclophosphamide enantiomers in patients with breast cancer
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry
- Enantioselective pharmacokinetics of lercanidipine in healthy volunteers
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics
- Influence of lercanidipine in the kinetic sisposition of fluvastatin enantiomers in healthy volunteers
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
- Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study
Informações sobre o DOI: 10.1007/s00280-011-1554-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
